Company profile for Exeltis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Exeltis is an organization committed to innovation, excellence and healthcare. Our aim is to become a point of reference in the pharmaceutical sector. A step forward in improving health Exeltis is the result of the natural evolution and sustained growth of the CHEMO pharmaceutical business, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a...
Exeltis is an organization committed to innovation, excellence and healthcare. Our aim is to become a point of reference in the pharmaceutical sector. A step forward in improving health Exeltis is the result of the natural evolution and sustained growth of the CHEMO pharmaceutical business, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a global organization with the capacity to discover, develop, produce and market medicinal products and medical devices that can help to improve the quality of life of millions of people worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Manuel Pombo Angulo, 28, third floor, Madrid, Madrid 28050
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accesswire.com/956406/theranexus-and-exeltis-insud-pharma-announce-licensing-agreement-to-commercialize-theranexus-tx01-for-two-rare-neurological-disorders

ACCESSWIRE
17 Dec 2024

https://www.businesswire.com/news/home/20240507867076/en

BUSINESSWIRE
08 May 2024
FDA blasts Exeltis over ‘misleading’ post about contraceptive
FDA blasts Exeltis over ‘misleading’ post about contraceptive

23 Aug 2023

// Nick Paul Taylor FIERCE PHARMA

https://www.fiercepharma.com/marketing/fda-blasts-exeltis-over-misleading-social-media-post-about-birth-control-drug

Nick Paul Taylor FIERCE PHARMA
23 Aug 2023

https://endpts.com/birth-control-drugmaker-hit-with-fda-letter-over-misleading-social-media-promotion/

Beth Snyder Bulik ENDPTS
21 Aug 2023

https://www.prnewswire.com/news-releases/lupin-signs-promotional-agreement-with-exeltis-on-solosec-secnidazole-expanding-access-for-adult-women-suffering-with-bacterial-vaginosis-and-adults-with-trichomoniasis-301469860.html

PRNEWSWIRE
27 Jan 2022

https://www.globenewswire.com/news-release/2021/09/07/2292923/0/en/IntelGenx-Announces-Market-Launch-of-RIZAPORT-in-Spain.html

GLOBENEWSWIRE
07 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty